GlassScriptPhysician profile
Naseer Khan
NPI 1144471020
$1,070.60
in general payments reported to CMS, 2019-2025
15 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.44 · 2020: $18.75 · 2021: $63.67 · 2022: $73.63 · 2023: $314 · 2024: $399 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $425.67 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Teleflex LLC | $165.57 | 2023-2024 | Guideliner |
| Abiomed | $94.78 | 2024-2025 | Impella |
| W. L. Gore & Associates, INC. | $66.67 | 2019 | |
| Cardiva Medical, INC. | $51.90 | 2022 | |
| Abbott Laboratories | $49.80 | 2021 | |
| Stryker Corporation | $48.98 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Medtronic, INC. | $43.24 | 2024 | Symplicity G3 |
| Merck Sharp & Dohme LLC | $35.60 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $20.99 | 2024 | Arcalyst |
| Chiesi USA, INC. | $20.88 | 2023 | Kengreal |
| Boston Scientific Corporation | $18.75 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.45 | 2019 | |
| Ekos Corporation | $12.32 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naseer Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.